BARBARA PAULO: Open Payments
NPI 1609546027 · MIAMISBURG, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,302 in 78 payments from 15 companies in 2025. Trend: 2023 $336 · 2024 $934 · 2025 $1,302
Food & beverage: $1,302
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $475 |
| Otsuka America Pharmaceutical, Inc. | 18 | $184 |
| Vanda Pharmaceuticals Inc. | 7 | $143 |
| Axsome Therapeutics, Inc. | 5 | $137 |
| Alkermes, Inc. | 2 | $58 |
| Lundbeck LLC | 3 | $58 |
| Biogen, Inc. | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $31 |
| Corium, LLC | 2 | $29 |
Products named: VRAYLAR, REXULTI, Auvelity, HETLIOZ, FANAPT, ZURZUVAE, TRINTELLIX, VIVITROL.
Industry payments across OH — which companies pay providers there.
